Skip to main content

Perrigo's "Quitting is Better" Campaign Enters its Fourth Year of Partnership with the American Cancer Society

ACS Partnership 2020

Allegan, Michigan – November 19, 2020 – Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, is pleased to announce the fourth year of its “Quitting is Better” campaign in partnership with the American Cancer Society (ACS).

Since 2017, Perrigo has supported the American Cancer Society’s efforts to provide tools and resources for people seeking information, help, and guidance to quit smoking. The ACS is committed to attacking cancer from every angle, which includes helping people quit smoking. Tobacco use is the leading preventable cause of cancer and cancer deaths in the United States. 

This year’s exclusive partnership for Perrigo’s nicotine replacement therapy (NRT) smoking cessation products promises to be the most successful campaign to date with a first-of-its-kind store brand category promotion available to all of the Company’s customers.  As part of the campaign partnership, Perrigo is providing participating retailers with print and digital promotional materials, including on-pack messaging, shelf signage, store displays, store circular advertisements, and digital content to support online offers and loyalty programs.

The promotion aligns with today’s ACS Great American Smokeout® event, when thousands of people across the country who smoke take an important step toward a healthier life and reduced cancer risk.   During this campaign, consumers can access the ACS’s resources and support and purchase Perrigo’s affordable store brand NRT products at participating retailers throughout the U.S. until the end of January. 

“We are very pleased to enter our fourth year of partnership with the ACS.  This partnership has been highly effective in driving awareness and incremental sales for store brand NRT products, while providing consumers with access to ACS’s smoking database and research to help them get the resources they need to quit smoking,” commented Angela Gusse, Perrigo’s Marketing Director for the Skincare & Personal Wellness and Healthy Lifestyles categories.  “Our NRT products advance our vision and self-care strategy while improving the health and wellness of consumers.  We are excited to build on our successful partnership with the ACS and help even more people quit tobacco use.”

Howard Byck, Senior Vice President of Corporate and Sports Alliances at the American Cancer Society, remarked, “We know that decreasing and ultimately eliminating tobacco usage also decreases the risk for lung and many other cancers and Perrigo’s nicotine replacement products closely align with our mission to save lives.”  Byck continued, “For four years, Perrigo has partnered with the American Cancer Society through its “Quitting is Better” Campaign, and we could not be more appreciative of their support.”

Perrigo’s healthy lifestyle product portfolio comprises mainly smoking cessation and NRT products, including a full range of oral nicotine offerings to help smokers kick the habit or cut down on tobacco use. Smokers can choose from coated or uncoated gum and regular or mini lozenges. Flavors include Mint, Fruit, Citrus, Cherry and Cinnamon and come in 2 mg and 4 mg strengths. Perrigo NRT products can be found across the retail marketplace in many retail stores and online.

About Perrigo

Perrigo Company plc (NYSE; TASE: PRGO) is a leading provider of Quality, Affordable Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Led by its consumer self-care strategy, Perrigo is the largest store brand OTC player in the U.S. in the categories in which it competes through more than 9,000 SKUs under customer ‘own brand’ labels. Additionally, Perrigo is a Top 5 OTC company by revenue in Europe, where it markets more than 200 branded OTC products throughout 28 countries. The Company also commercializes and manufactures generic prescription products in the U.S. Visit Perrigo online at  

Lyndsey Chmiel, Senior Manager, Global Investor Relations & Corporate Communications, (269) 673-9324, E-mail:

Cory Ziskind, Managing Director, ICR, (646) 277-1232, E-mail:

Press Inquiries

If you are a member of the press on deadline, please reach out to a member of our Global Investor Relations & Corporate Communications team.